Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Peptide Stacking: Research Protocol Comparison

The table below compares three of the most common BPC-157 stacking protocols used in research models, outlining mechanism synergy, typical dosing ranges, administration frequency, and professional assessment of each combination. BPC-157 + TB-500 Angiogenesis (

This comparison does not assign a generated winner or score.

  • The table below compares three of the most common BPC-157 stacking protocols used in research models, outlining mechanism synergy, typical dosing ranges, administration frequency, and professional assessment of each combination.
  • BPC-157 + TB-500
  • Angiogenesis (BPC-157) + actin upregulation and systemic tissue repair (TB-500)
  • BPC-157: 250–500mcg/day; TB-500: 2–5mg twice/week
  • BPC-157 daily; TB-500 twice weekly
  • Most widely documented stack for musculoskeletal injury models. Mechanisms do not overlap. BPC-157 provides localized angiogenic effects while TB-500 supports systemic cell migration and structural repair. Compatible with subcutaneous administration at separate sites.
  • BPC-157 + Ipamorelin
  • Angiogenesis (BPC-157) + growth hormone secretagogue (Ipamorelin via ghrelin receptor)
  • BPC-157: 250–500mcg/day; Ipamorelin: 200–300mcg/day
  • Both daily, can be administered at different times
  • Mechanistically compatible. No receptor competition. Useful in models exploring tissue repair alongside growth hormone modulation. Ipamorelin's pulsatile GH release does not interfere with BPC-157's VEGFR2 signaling. Timing separation (AM for Ipamorelin, PM for BPC-157) optimizes GH response.
  • BPC-157 + Thymosin Alpha-1
  • Angiogenesis (BPC-157) + immune modulation via T-cell differentiation (Thymosin Alpha-1)
  • BPC-157: 500mcg twice/week; Thymosin Alpha-1: 750mcg–1.6mg twice/week
  • Both twice weekly, can be co-administered
  • Addresses two distinct research endpoints: vascular repair and immune coordination. No receptor interference. Frequently paired in post-surgical recovery models or chronic inflammatory research. Both peptides are stable in bacteriostatic water and can be stored under identical conditions (2–8°C).
More references

Related material